Close Menu

NEW YORK – Medical device company Magnolia Medical announced Thursday a collaboration with Cardinal Health to distribute Magnolia's Steripath Gen2 Initial Specimen Diversion Device, which works to reduce blood culture contamination.

Cardinal Health will offer the device to hospitals as a standalone product or as part of a customizable best practice kit, with the goal of reducing false-positive diagnostic results for sepsis from blood contamination.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.